← Eichor
Study identifier: NCT06326996 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Thiamine Intervention and Coronary Artery Bypass Grafting

Condition: Coronary Heart Disease · Coronary Artery Bypass Grafting  ·  Sponsor: University of California, Los Angeles

PhaseEARLY_Phase 1
Planned participants52
Who can joinAll sexes, 60 Years to 80 Years
Healthy volunteersNo

About this study

The purpose of this study is to gain a better understanding of the association between brain changes and cognitive deficits in coronary heart disease (CHD) patients undergoing coronary artery bypass grafting (CABG) and whether a low-cost thiamine intervention can be used to reduce post-CABG cognitive issues in CHD subjects.

This description comes directly from the study's public registry record.

Talk to the study team

Rajesh Kumar, PhD  ·  310-206-1699  ·  rkumar@mednet.ucla.edu

Dineth Karunamuni, MS  ·  856-701-5332  ·  dkarunamuni@mednet.ucla.edu

Always discuss trial participation with your own doctor first.

Locations (1)

UCLALos Angeles, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06326996